Quest Diagnostics Inc vs Estee Lauder Companies Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Estee Lauder Companies Inc trades at $88.01 (market cap $31.76B). The key difference: Estee Lauder Companies Inc is the larger of the two by market cap, and Estee Lauder Companies Inc pays the higher dividend (1.59%). Which is the better fit depends on your goals.
| DGX | EL | |
|---|---|---|
Market Cap | $26.21B | $31.76B |
Sector | Health | Consumer Staples |
52-Week High | $238.50 | $119.61 |
52-Week Low | $173.49 | $67.23 |
Enterprise Value | $31.97B | $37.93B |
Dividend Yield | 1.45% | 1.59% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Read more on EL →